FDA Approves First Alzheimer's Drug

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/2c/1d/25/2c1d251f-bfcc-e590-8815-9fb3bc7d0b82/mza_8714065625004903258.jpeg/600x600bb.jpg

Concord News Today | 2 Min News | The Daily News Now!

The Daily News Now!

530 episodes

6 hours ago

Concord News Today provides clear, fast two-minute updates — voiced by DNN Founder Corey — covering New Hampshire’s capital region, including statehouse news, weather, schools, business, and community events. Powered by The Daily News Now Network, your local coverage stays continuous and reliable. Subscribe now for nonstop Concord news.

Hosted on Acast. See acast.com/privacy for more information.

Daily News

News

RSS

All content for Concord News Today | 2 Min News | The Daily News Now! is the property of The Daily News Now! and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Hosted on Acast. See acast.com/privacy for more information.

Daily News

News

https://assets.pippa.io/shows/6885d71b97fd91bee2787884/1764152043683-fa6d26b9-f8fb-4b88-bb42-1d39b1b7f955.jpeg

FDA Approves First Alzheimer's Drug

Concord News Today | 2 Min News | The Daily News Now!

1 minute 35 seconds

3 days ago

FDA Approves First Alzheimer's Drug

FDA Approves First Drug for Early Alzheimers: Leqembi Offers New Hope - The FDA has given full approval to Leqembi, the first drug designed to treat early Alzheimers disease. This medication targets amyloid plaques in the brain, slowing down the diseases progression. The full approval opens the door for broader insurance coverage, including Medicare, but its important to note that Leqembi is not a cure and has potential side effects.

DNN | The Daily News Now!

The world’s first global local news network.

Every city. Every story. AI powered.

Hosted on Acast. See acast.com/privacy for more information.